openPR Logo
Press release

Veterinary Diagnostics Market to Reach USD 15.75 Billion by 2033 as Technology Convergence and Preventive Animal Healthcare Priorities Reshape the Sector with North America Holding 34% Share Led by IDEXX Laboratories, Zoetis Inc. and Thermo Fisher Scienti

05-14-2026 01:18 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Veterinary Diagnostics Market

Veterinary Diagnostics Market

The Global Veterinary Diagnostics Market reached USD 8.82 billion in 2025 and is projected to witness lucrative growth by reaching up to USD 15.75 billion by 2033. The global veterinary diagnostic smarket is expected to exhibita CAGR of 8.7% during the forecast period 2026-2033 driven by the rising prevalence of animal diseases, increasing pet ownership, and growing demand for advanced diagnostic technologies in livestock and companion animal healthcare.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/veterinary-diagnostics-market?sindhuri

Growth is strongly supported by expanding applications across infectious disease testing, clinical biochemistry, immunodiagnostics, hematology, urinalysis, and molecular diagnostics, used extensively in both companion animals and livestock health management. The increasing focus on early disease detection, preventive veterinary care, and food safety is significantly boosting demand for rapid and accurate diagnostic solutions.

Additionally, rising concerns over zoonotic diseases, antimicrobial resistance, and livestock productivity are accelerating the adoption of advanced veterinary diagnostic platforms. Technologies such as PCR-based testing, ELISA, immunoassays, and point-of-care (POC) diagnostic kits are witnessing strong uptake due to their speed, accuracy, and ease of use in field settings.

The rapid expansion of pet healthcare expenditure, especially in developed markets, along with government-led animal health surveillance programs, is further supporting market growth. Emerging economies are also witnessing increased investment in veterinary infrastructure and diagnostic laboratories.

Veterinary Diagnostics Market: Regional Insights
North America remains the dominant market, driven by high pet ownership rates, advanced veterinary healthcare infrastructure, and strong presence of leading diagnostic companies.
Europe follows closely due to strict animal health regulations and strong livestock monitoring systems.
Asia-Pacific is expected to be the fastest-growing region, supported by rising livestock production, increasing awareness of animal health, and expanding veterinary services in countries such as China and India.

Veterinary Diagnostics Market: Competitive Intelligence
IDEXX Laboratories, Zoetis Inc., Thermo Fisher Scientific Inc., bioMérieux SA, Heska Corporation (now part of Mars Petcare), Virbac, Neogen Corporation, Fujifilm Holdings Corporation, Randox Laboratories Ltd., and INDICAL Bioscience are among the major global players shaping the competitive landscape of the Veterinary Diagnostics Market.

These companies offer a wide range of solutions including diagnostic analyzers, rapid test kits, molecular diagnostic systems, immunoassay platforms, and veterinary point-of-care devices used across animal hospitals, diagnostic laboratories, and on-farm testing environments.

The market is primarily driven by the increasing need for early disease detection, livestock productivity optimization, and companion animal health monitoring, along with growing investments in veterinary healthcare infrastructure globally.

Competitive differentiation is driven by advancements in rapid molecular diagnostics, portable point-of-care testing devices, AI-powered diagnostic platforms, and integrated veterinary data management systems. IDEXX Laboratories leads in integrated diagnostic ecosystems, while Zoetis focuses on animal health innovation and preventive care solutions. Thermo Fisher and bioMérieux strengthen molecular and laboratory-based diagnostic capabilities, while emerging players focus on affordability and rapid field testing solutions.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/veterinary-diagnostics-market?sindhuri

Recent Key Developments - United States & North America
✅ June 2025: Rising demand for rapid and point-of-care veterinary diagnostics driven by increasing pet ownership, livestock health monitoring, and zoonotic disease surveillance, accelerating adoption of advanced diagnostic platforms across North America.
✅ May 2025: Strong expansion of veterinary diagnostic laboratories and reference testing networks in the United States supported growth in molecular diagnostics, immunodiagnostics, and clinical biochemistry testing services.
✅ 2025: Growing focus on animal health security and food safety regulations boosted investments in early disease detection technologies and automated veterinary diagnostic systems across the region.

Recent Key Developments - Europe & Asia-Pacific
✅ July 2025: Expansion of companion animal healthcare infrastructure in Europe and Asia-Pacific increased demand for advanced imaging, hematology, and infectious disease diagnostic solutions.
✅ Early 2026: Rising livestock disease outbreaks and government-led animal health programs in countries such as China, India, and Australia accelerated adoption of veterinary PCR and rapid testing kits.
✅ 2025: Increasing veterinary R&D investments and collaborations between diagnostic companies and animal health providers strengthened innovation in precision veterinary diagnostics across the region.

Recent Key Developments - Product & Technology Innovation
✅ 2025: Molecular Diagnostics Expansion: Advancements in PCR, qPCR, and next-generation sequencing (NGS) improved accuracy and speed in detecting infectious and genetic diseases in animals.
✅ AI-Enabled Veterinary Diagnostics: Integration of artificial intelligence and cloud-based platforms enhanced imaging interpretation, predictive disease modeling, and clinical decision support in veterinary care.
✅ Point-of-Care & Portable Testing: Growth in handheld analyzers and rapid diagnostic kits enabled faster on-site disease detection, improving treatment outcomes and reducing turnaround time in both companion and livestock animals.

M&A / Strategic Activity
Recent strategic acquisitions, partnerships, and ecosystem developments shaping the Veterinary Diagnostics Market:

IDEXX Laboratories - Portfolio expansion & ecosystem strengthening
IDEXX Laboratories continues to reinforce its dominance through acquisitions and platform integration, expanding its veterinary diagnostic ecosystem across in-clinic analyzers, reference laboratory services, and cloud-connected diagnostic software supporting companion animal healthcare globally.

Zoetis - Diagnostic and precision animal health expansion
Zoetis has been actively investing in veterinary diagnostics and precision animal health solutions, strengthening its portfolio through targeted acquisitions and collaborations in biomarker-based testing, parasitology diagnostics, and point-of-care testing platforms.

Thermo Fisher Scientific - Veterinary lab diagnostics integration
Thermo Fisher Scientific is expanding its presence in veterinary diagnostics via advanced molecular testing platforms, PCR-based infectious disease detection systems, and laboratory automation technologies adapted for veterinary applications.

Heska Corporation - Companion animal diagnostic consolidation
Heska Corporation has been strengthening its position through strategic partnerships and integration with larger animal health ecosystems, focusing on immunodiagnostics, chemistry analyzers, and reference lab services for veterinary clinics.

Boehringer Ingelheim - Animal health & diagnostic collaborations
Boehringer Ingelheim continues to expand its animal health division through collaborations supporting diagnostic-driven treatment pathways, improving early disease detection in livestock and companion animals.

New Product Launches & Diagnostic Innovations
Recent innovations and deployments in the veterinary diagnostics space:

IDEXX Laboratories - AI-enabled diagnostic analyzers
IDEXX Laboratories has introduced advanced in-clinic analyzers integrated with AI-supported interpretation tools, improving speed and accuracy of hematology, biochemistry, and urinalysis testing in veterinary practices.

Zoetis - Next-generation rapid diagnostic tests
Zoetis has expanded its rapid diagnostic portfolio for infectious diseases, enabling faster detection of parasitic and bacterial infections in companion animals and livestock.

Thermo Fisher Scientific - Molecular veterinary testing platforms
Thermo Fisher Scientific continues to deploy PCR-based and multiplex molecular testing systems adapted for veterinary pathogens, improving sensitivity in early disease detection.

Virbac - Point-of-care diagnostics expansion
Virbac is expanding its diagnostic ecosystem with point-of-care testing kits focused on dermatology, parasitology, and preventive screening in companion animals.

IDEXX Laboratories - Cloud-connected diagnostics platforms
IDEXX Laboratories continues to enhance digital connectivity between veterinary clinics and laboratories, enabling real-time data sharing, workflow automation, and predictive analytics.

R&D & Technological Advancements
AI-driven veterinary diagnostics
Artificial intelligence is being integrated into imaging, hematology, and pathology workflows to improve disease prediction, automate result interpretation, and reduce diagnostic turnaround times.

Molecular and genomic testing in animal health
Advances in PCR, next-generation sequencing (NGS), and multiplex assays are enabling highly accurate detection of zoonotic and species-specific diseases.

Point-of-care (POC) testing expansion
Portable diagnostic devices are improving access to rapid testing in clinics, farms, and remote veterinary settings, especially for infectious disease screening.

Digital pathology & cloud-based diagnostics
Cloud-enabled platforms are transforming veterinary diagnostics by enabling remote consultations, centralized data storage, and AI-assisted pathology review.

Biomarker-based early disease detection
Research is accelerating in biomarker discovery for early identification of chronic diseases such as kidney disorders, cancer, and metabolic conditions in animals.

Market Drivers & Emerging Trends
» Rising pet ownership and increasing expenditure on companion animal healthcare are significantly boosting demand for advanced veterinary diagnostics.
» Growing prevalence of zoonotic and infectious diseases is driving adoption of rapid and molecular diagnostic solutions.
» Expansion of livestock production and food safety regulations is increasing demand for large-scale veterinary testing.
» Technological advancements in AI, molecular diagnostics, and automation are improving accuracy and efficiency in veterinary laboratories.
» Increasing shift toward preventive veterinary care is fueling demand for early screening and wellness diagnostics.
» Expansion of veterinary clinic networks and reference laboratories is strengthening global diagnostic infrastructure.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=veterinary-diagnostics-market?sindhuri

Segments Covered in the Global Veterinary Diagnostics Market:
By Product Type
The market is segmented into analyzers (55%) and consumables (45%). Analyzers dominate the market due to the increasing adoption of automated diagnostic systems in veterinary laboratories and clinics, enabling faster and more accurate disease detection. Consumables are witnessing steady demand driven by the recurring requirement for reagents, test kits, and diagnostic strips used across routine testing procedures in veterinary healthcare settings.

By Technology
The market is segmented into immunodiagnostics (30%), clinical biochemistry (25%), hematology (20%), molecular diagnostics (15%), and others (10%). Immunodiagnostics leads the segment owing to its widespread use in detecting infectious diseases and monitoring immune responses in animals. Clinical biochemistry and hematology are widely used for routine health assessment and disease screening, while molecular diagnostics is growing rapidly due to its high accuracy in detecting genetic and infectious conditions.

By Animal Type
The market is segmented into companion animals (60%) and livestock (40%). Companion animals dominate the segment due to rising pet adoption, increasing expenditure on pet healthcare, and growing awareness of preventive diagnostics. Livestock diagnostics remains essential for food safety, herd health management, and prevention of infectious disease outbreaks in commercial farming systems.

By Application
The market is segmented into infectious diseases (35%), endocrinology & oncology (20%), autoimmune disorders (10%), bone and mineral diseases (10%), and others (25%). Infectious diseases lead the segment due to the high prevalence of zoonotic and viral infections in both companion and livestock animals. Endocrinology and oncology are also expanding with increasing diagnosis of chronic and age-related conditions in pets.

By End User
The market is segmented into veterinary hospitals & clinics (45%), reference laboratories (30%), and point-of-care/in-house testing (25%). Veterinary hospitals and clinics hold the largest share due to their primary role in animal diagnosis and treatment. Reference laboratories support complex and large-scale testing, while point-of-care testing is growing rapidly due to demand for quick, on-site diagnostic results.

By Region
North America (34%) leads the market due to advanced veterinary healthcare infrastructure, high pet ownership, and strong adoption of diagnostic technologies.
Europe (28%) follows, driven by strict animal health regulations, strong veterinary networks, and rising awareness of zoonotic diseases.
Asia-Pacific (30%) is witnessing rapid growth due to expanding livestock population, rising pet adoption, and improving veterinary healthcare systems in countries such as China, India, and Japan.
Latin America (5%) is growing steadily with increasing livestock farming and veterinary service expansion.
Middle East & Africa (3%) is emerging gradually with improving animal healthcare infrastructure and growing investment in veterinary services.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact:
Fabian
DataM Intelligence 4market Research LLP 6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Veterinary Diagnostics Market to Reach USD 15.75 Billion by 2033 as Technology Convergence and Preventive Animal Healthcare Priorities Reshape the Sector with North America Holding 34% Share Led by IDEXX Laboratories, Zoetis Inc. and Thermo Fisher Scienti here

News-ID: 4513766 • Views:

More Releases from DataM Intelligence 4Market Research LLP

Future of Telehealth Market 2026 | Market is set to reach US$ 478.18 Billion by 2033, led by North America with 40% Market Share | Major Players:- Epic Systems, Oracle, athenahealth, eClinicalWorks & GE HealthCare
Future of Telehealth Market 2026 | Market is set to reach US$ 478.18 Billion by …
The Telehealth Market reached US$ 138.59 billion in 2025 and is expected to reach US$ 478.18 billion by 2033, growing at a CAGR of 17.2% during the forecast period 2026-2033. Growth is driven by the increasing adoption of digital healthcare solutions that enable remote consultations, diagnostics, and patient monitoring. Telehealth platforms improve accessibility, convenience, and cost efficiency, particularly for patients in remote and underserved regions. Additionally, rising demand for chronic disease
Future of Nuclear Reactor Decommissioning Market 2026 | Market is set to reach US$ 99.50 Billion by 2033, led by Europe with 35% Market Share | Major Players:- Westinghouse, Orano, SNC-Lavalin (AtkinsRéalis), Bechtel & AECOM
Future of Nuclear Reactor Decommissioning Market 2026 | Market is set to reach U …
The Nuclear Reactor Decommissioning Market reached US$ 82.90 billion in 2025 and is expected to reach US$ 99.50 billion by 2033, growing at a CAGR of 2.7% during the forecast period 2026-2033. Growth is driven by the increasing number of aging nuclear reactors reaching end-of-life, particularly in developed regions such as North America and Europe. Decommissioning activities involve safe dismantling, waste management, and site decontamination, ensuring environmental and public safety. Additionally,
Endoscopy Devices Market to Reach USD 109.50 Billion by 2033 as AI-Powered Minimally Invasive Technologies and Precision Diagnostics Transform Modern Healthcare with North America Holding 36% Share Led by Olympus Corporation, Medtronic plc and Boston Scie
Endoscopy Devices Market to Reach USD 109.50 Billion by 2033 as AI-Powered Minim …
The Global endoscopy devices market reached USD 62.30 billion in 2025 and is expected to reach USD 109.50 billion by 2033, growing with a CAGR of 7.3% during the forecast period 2026-2033 driven by the rising demand for minimally invasive procedures, increasing prevalence of gastrointestinal and chronic diseases, and continuous advancements in endoscopic imaging and visualization technologies. Download your exclusive sample report today (corporate email gets priority access): https://www.datamintelligence.com/download-sample/endoscopy-devices-market?sindhuri Growth is strongly
Future of North America Carbon Nanotubes Market 2026 | Market is set to reach US$ 5.39 Billion by 2033, led by Multi-Walled CNTs with 65% Market Share | Major Players:- LG Chem, Arkema, Nanocyl, NanoLab & Kumho Petrochemical
Future of North America Carbon Nanotubes Market 2026 | Market is set to reach US …
According to DataM Intelligence (DMI), the North America Carbon Nanotubes Market was valued at US$ 1.54 billion in 2025 and is expected to reach US$ 5.39 billion by 2033, growing at a CAGR of 16.9% during the forecast period 2026-2033. Growth is driven by increasing demand for advanced materials with superior strength, conductivity, and lightweight properties across industries such as electronics, aerospace, automotive, and energy. Carbon nanotubes (CNTs) are widely used

All 5 Releases


More Releases for Diagnostic

Rubella Diagnostic Testing Market Report 2024 - Rubella Diagnostic Testing Marke …
"The Business Research Company recently released a comprehensive report on the Global Rubella Diagnostic Testing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive
Diagnostic Electrocardiograph Market - Elevating Cardiac Care: Diagnostic Electr …
Newark, New Castle, USA: The "Diagnostic Electrocardiograph Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Electrocardiograph Market: https://www.growthplusreports.com/report/diagnostic-electrocardiograph-market/7804 This latest report researches the industry structure, sales, revenue,
Diagnostic Imaging Market - Empowering Precision Medicine: Harnessing the Potent …
Newark, New Castle, USA: The "Diagnostic Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2021 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Diagnostic Imaging Market: https://www.growthplusreports.com/report/diagnostic-imaging-market/7688 This latest report researches the industry structure, sales, revenue,
Rubella Diagnostic Testing Market - Advancing Rubella Control: Innovating Diagno …
Newark, New Castle, USA - new report, titled Rubella Diagnostic Testing Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rubella Diagnostic Testing market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rubella Diagnostic Testing market. The report offers an overview of
Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends